Background
Colorectal cancer (CRC), also known as colon cancer, is one of the principle malignancies worldwide. Although improvements have been made in the diagnosis and treatment, CRC remains the top leading cause of cancer-related death [
1,
2]. The metastasis usually occurs in the late stage of CRC in which tumor cells detach from the primary tumor, invade into surrounding tissue or vessels, migrate and colonize at distant organs such as liver and lung. Metastasis is the main cause of CRC-related death, thus uncovering the molecular mechanisms and identification of new diagnostic markers are in emerging need during current CRC studies. The progress of normal intestinal epithelial cell transition to unregulated cancer cell is a multi-stage and complicated process which is associated with the accumulation of both genetic and epigenetic changes. The aberration, mutations of oncogenes or tumor suppressive genes, and epigenetic alterations all lead to the progression of CRC [
3‐
6].
Long non-coding RNAs (lncRNAs) are defined as a class of RNA transcripts with length over 200 nucleotides and lack of protein-coding capacity, many of which exhibit specific cell-type and developmental-stage expression pattern [
7,
8]. Emerging studies find that lncRNAs play crucial roles in a variety of cellular events, including transcriptional regulation of genes, cell proliferation, cell differentiation, cell cycle and apoptosis [
9‐
11]. To date, mounting literatures have reported that the aberrant level of lncRNAs in numerous cancer is involved in carcinogenesis, tumor metastasis in diverse cancer types and can be considered as indicators for diagnosis and patient outcomes of cancer, such as prostate cancer, breast cancer, gastric cancer and CRC [
12‐
16].
MicroRNAs are single-strand RNAs (18–22nt), which bind to seed sequences of 3′-untranslated regions (UTRs) of target genes to mediate translation inhibition [
17]. LncRNAs exert their roles in genes expression network by affecting chromatin modification, mRNA transcription and interacting with RNA binding proteins [
18‐
20]. In addition, lncRNAs also act as “miRNA sponges” and sequester miRNAs to modify miRNAs target genes transcription, which has been identified as the lncRNA-miRNA-mRNA regulatory network in cancer tumorigenesis and progression [
21,
22]. For examples, LINC01287 regulates tumorigenesis of hepatocellular carcinoma via miR-298/MYB axis [
23]. LncRNA SNHG15 promotes the proliferation and migration of lung cancer through targeting microRNA-211-3p [
16]. LncRNA TUG1 sponges miR-145 to expedite cancer progression via modulating Sirt3/GDH axis [
24].
Although a growing number of lncRNAs have been annotated in past decades, the role and potential regulatory mechanisms of uncharacterized lncRNAs in CRC still need to be clarified for exploration of potential diagnostic markers and therapeutic targets [
25]. In the present study, we investigated lncRNAs expression profile in CRC by RNA sequencing (RNA-seq) based on Cancer Genome Atlas (TCGA) and characterized the role of long non-coding RNA LINC02418 as a novel oncogene in colon cancer. Mechanism analysis revealed that LINC02418 acted as competing endogenous RNA (ceRNA) for miR-34b-5p to prevent the degradation of BCL. Our results highlighted that LINC02418/miR-34b-5p/BCL2 axis might be a promising therapeutic target for CRC treatment.
Materials and methods
Clinical specimens
Tumor tissues and adjacent tissues from CRC patients (n = 20) were collected from China-Japan Union Hospital of Jilin University and all the participants signed the consent forms. Among the 20 patients, 11 patients were male and 9 patients were female. The average age of included patients was 59.75 ± 9.00 years old. The enrolled patients were pathologically diagnosed as CRC and did not undergo preoperative radiotherapy and/or chemotherapy prior to resection. The project was authorized by the Ethical and Scientific Committee of China-Japan Union Hospital of Jilin University. All samples were stored at − 80 °C until subsequent analysis.
Cell culture
Human CRC cell lines including SW460, HCT116, HT-29, LoVo, Colo205, SW480 and normal colon epithelial cell line NCM460 were obtained from American Type Culture Collection (ATCC, Manassas, VA). Cells were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum (Gibco, Carlsbad, CA), 100U/ml penicillin and 100 mg/ml streptomycin. Cells were normally maintained at 37 °C in an incubator with 5% CO2 until use.
Cells transfection
The sequence of BCL2 was inserted into vector pcDNA3.1 (Santa Cruz, Dallas, TX) for its ectopic expression in HCT116 and LoVo cell lines. Constructions, miR-34b-5p mimic, miR-34b-5p inhibitor and miR-NC mimic were delivered into CRC cells by Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA) according to manufactures instructions.
Establishment of stable cell lines
Three shRNAs sequences targeting LINC02418 and negative control sequence were inserted into HuSH shRNA GFP Lenti Cloning Vector (Origene, Rockville, MD) following commercial guidance. The lentivirus was packaged using 293T cells following common protocols.
Cell counting kit-8 analysis and colony formation assay
For CCK-8 experiment, the cells were seeded at density of 5 × 104 cells per well on 48-well plate. Cells were harvested at 12 h, 24 h, 48 h and 72 h, and cell proliferation was assessed using cell counting kit-8 (Beyotime, Shanghai, CHA) according to the manufacturer’s instructions. The optical density (OD) at 450 nm was measured using a microplate reader (Thermo Fisher Scientific, Waltham, MA).
For colony formation assay. Total number of 3000 cells were seeded in 6-well plates and maintained in RPMI 1640 medium containing 10% FBS. After culture of 14 days, cells were fixed with 4% paraformaldehyde for 15 min and then stained with 0.1% crystal violet (Sigma-Aldrich, St. Louis, MO) for another 5 min till manually counting of visible colonies.
Xenograft assay
Male BALB/c nude mice (5–6 weeks old) were maintained under specific pathogen-free facility and were manipulated according to protocols approved by the China-Japan Union Hospital of Jilin University. All the mice were randomly divided into four groups, and each group contained 5 mice.
HCT116-sh-LINC02418, HCT116-sh-NC, LoVo-sh-LINC02418 and LoVo-sh-NC cells (2 × 106 cells) resuspended in 200 μl of medium were subcutaneously inoculated into nude mice. After 7 days post-injection, tumor size was measured every 3 days, and the tumor volumes were recorded. After 21 days post-injection, mice were sacrificed by cervical dislocation. Tumors were separated from mice and the weight of tumor was measured. The survival curve analysis was not involved in this experiment.
Transwell migration and invasion assay
Cells migration assays were performed in a 24-well transwell chamber (CoStar, Badhoevedorp, Netherlands). Cells were plated and allowed to migrate through 8 μm-pore sized polycarbonate membrane. The chamber for invasion assay was pre-coated with 1 mg/ml Matrigel (Sigma-Aldrich, St. Louis, MO). A number of 5 × 104 cells were added to the upper chamber of the transwells with FBS-free medium and the lower chamber was filled with 500 μl RPMI 1640 medium containing 10% FBS. After 24 h incubation, the cells were fixed by 4% formaldehyde for 10 min, stained by 0.1% crystal violet for 20 min. Images were captured under microscope.
Quantitative reverse transcription PCR (qRT-PCR) assay
Total RNA was extracted from clinical tissue and CRC cells by TRIzol reagent (Invitrogen, CA, USA). RNA reverse transcription for mRNA and miRNA was performed using Prime ScriptTM RT Master Mix (Takara, Otsu, Japan) and TaqMan MicroRNA Reverse Transcription system (Thermo Fisher Scientific, MA, USA), respectively. The quantitative PCR was carried out by SYBR Premix Ex Taq II (TaKaRa Biotechnology, Dalian, China). Commercial miRNA qRT-PCR primers for miR-34b-5p and U6 were purchased by RiboBio (Guangzhou, China). The available primers sequences were as follows: LINC02418-F: 5′-ATTTCCATGGCGTTTCTCAC, LINC02418-R: 5′-AGGCAGGAGAATTGCTTGAA; BCL2-F: 5′-GGCATCTTCTCCTTC CAG-3′, BCL2-R: 5′-CATCCCAGCCTCCGTTAT-3′; GAPDH-F:5′-ACAACTTTGGTATCGTGGAAGG-3′, GAPDH-R:5′GCCATCACGCCACAGTTTC-3′. Applied Biosystems 7900 Real-Time PCR System (Applied Biosystems, Foster City, CA) was used for RNA quantification assay. U6 and GAPDH were used as internal control of miRNAs and mRNAs, respectively. Fold change was calculated by the 2−△△Ct method.
Luciferase assay
The fragments containing the binding sites or the mutated sites were synthesized and inserted into a pGL3-basic vector for dual luciferase assay. HCT116 and LoVo Cells were seeded in a 12-well plate and co-transfected with reporter plasmids and miR-NC/miR-34b-5p mimic. After 48 h, cells were harvested, dual-luciferase reporter assays were performed according to the protocol using a Dual-Luciferase Reporter Assay System (Promega, Madison, WI) on a GloMax 20/20 luminometer (Promega, Madison, WI).
Fluorescence in situ hybridization (FISH) assay for miRNA
HCT116 and LoVo cells reaching 70% confluency were fixed in 4% paraformaldehyde for 20 min at room temperature, followed by permeabilized treatment in 70% ethanol at 4 °C overnight. For cellular miR-34b-5p detection, FISH assay was conducted following previous procedures [
26]. Specific Digoxigenin (DIG)–labeled locked nucleic acid (LNA) probe against miR-34b-5p was purchased from QIAGEN (Hilden, Germany). The 4′,6-diamidino-2-phenylindole (DAPI) (Invitrogen, CA, USA) was adopted to stain the cell nucleic.
Immunohistochemistry (IHC) assay
The tumor samples from CRC patients were fixed in 10% formaldehyde, embedded in paraffin and then sectioned into slices. For IHC assay, tumor slices were firstly deparaffinized and rehydrated. After washing, slices were treated with H2O2 to reduce the endogenous peroxidase activities. Slices were then incubated with primary antibody against BCL2 (1:50, Abcam, Cambridge, UK) overnight at 4 °C. With three times washing in PBS, the slides were incubated with secondary streptavidin–horseradish peroxidase-conjugated antibody (1:3000, Abcam, Cambridge, UK) for 1 h, and reacted with 3,3-diaminobenzidine tetrahydrochloride (DAB) solution (Yeasen Biotech, Shanghai, China) for 5 min. Finally, slides were counterstained with hematoxylin solution (Beyotime Biotechnology, Shanghai, CHN) for 1 min, dehydrated and mounted with neutral gum.
Western blot
Protein samples were separated on 10% sodium dodecyl sulphate–polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred to polyvinylidene fluoride membranes (PVDF) (Millipore, Billerica, MA) for protein bands detection. The membranes were blocked in 5% nonfat milk. Primary antibodies including anti-GAPDH (1:2000, Abmart, Shanghai, CHN), anti-BCL2 (1:500, Abcam, Cambridge, UK), anti-Caspase 9 (1:1000, Cell Signaling Techonolgy, MA, USA), anti-cleaved-Caspase 9 (1:500, Cell Signaling Techonolgy, MA, USA), anti-Caspase 3 (1:1000, Abcam, Cambridge, UK), and anti-cleaved-Caspase 3 (1:1000, Abcam, Cambridge, UK) were used for incubation overnight at 4 °C. The membranes were incubated with HRP-conjugated secondary antibody (1:3000, Jackson Immuno Research, PA, USA) at room temperature for 1 h and the protein bands were detected by Pierce Fast Western Blot Kit (Thermo Fisher Scientific, MA, USA).
Flow cytometric analysis
Apoptosis assays of HCT116 and LoVo cells were performed using Annexin V-FITC/propidium iodide (AV/PI) Apoptosis Detection Kit (Abcam, Cambridge, UK) according to the commercial instruction. Cells were incubated with ice-cold 75% ethanol at 4 °C overnight, followed by resuspending in 500 µl of 1 × Annexin V Binding Buffer. Then, cells were stained with 5 μl Annexin V/FITC and 5 μl Propidium Iodide (PI) in the dark for 15 min at the room temperature. Apoptosis rates were examined and analyzed by flow cytometry using FACS Calibur (BD Biosciences, CA, USA).
Statistical analysis
Statistical data analysis was conducted using GraphPad Prism 6.0 (GraphPad Software, Inc., La Jolla, CA). Experiments were carried out in triplicate and the data was displayed as mean ± SD. Statistical analysis was conducted using Student’s t test or one-way analysis of variance. Statistical significance was considered when p < 0.05.
Discussion
Colon cancer is one common malignancy of digestive tract and has been one of the most serious healthy threaten worldwide. There is urgent need to explore more effective early diagnostic indicators and treatment strategies.
In this study, with analyzing of TCGA database, we found that LINC02418 level was up-regulated in CRC samples and cell lines, and was closely associated with prognosis of CRC (Fig.
1). Subsequently, we identified the effect of LINC02418 on CRC cells growth, migration and invasion (Fig.
2). Further bioinformatic screening and dual-luciferase assays showed that miR-34b-5p could bind to LINC02418 and BCL2 gene, and was negatively correlated with the amount of LINC02418 (Fig.
3 and Fig.
4). Finally, cell growth and colony formation experiments displayed that LINC02418 regulated CRC cells proliferation by regulating BCL2 via sponging miR-34b-5p (Fig.
5).
Long non-coding RNAs and microRNAs play multiple roles in tumor progression in almost all organs. The specificity expression in tissue and cells and high throughput detection technology make lncRNAs and miRNAs become potential diagnostic and therapeutic targets for clinical treatment [
7,
21,
22,
25]. In CRC patients, the high expression of LINC02418 correlated with poor prognosis of CRC and negatively correlated with the amount of miR-34b-5p, indicating LINC02418 abundance could be used as candidate indicator for CRC diagnosis and prognosis. If the expression of LINC02418 can be analyzed together with other clinical indicators, such as gender and age for comprehensive analysis, it may be possible to improve the accuracy of LINC02418 as a predictor in CRC.
Knockdown of LINC02418 decreased the CRC cell growth in vitro and in vivo and limited cell migration and invasion ability, indicating that LINC02418 was able to promote CRC progress and might have a vital role in regulating tumor development-associated signaling pathways. MicroRNAs are a group of small non-coding RNAs which bind to cognate mRNA via base pairing principles and decrease the expression of target gene either by translational repression or mRNA degradation [
17]. Profound evidence suggests that miRNAs are dysregulated in a variety of cancer tissues and may play distinct roles according to the type of cancer, disease stage, or the molecules that interact with it [
29‐
32].
Through competitively binding to microRNAs, lncRNAs attenuate the regulatory effect of microRNAs on target genes. The lncRNA/microRNA/mRNA network has already been proved to be critical for cancer occurrence and development. Bioinformatic analysis revealed that LINC02418 and 3′UTR region of
BCL2 contained complementary sequence of miR-34b-5p, implying miR-34b-5p could bind to LINC02418 and
BCL2 gene. MiR-34b-5p belongs to the miR-34 family which has been reported to be tumor suppressor and therapeutic candidate in cancer [
33‐
36]. Dual-luciferase activity assays confirmed the interaction between miR-34b-5p and LINC02418 (Fig.
3) or 3′UTR region of
BCL2 (Fig.
4). Moreover, quantification assays determined that expressional level of miR-34b-5p was negatively correlated with the amount of LINC02418 and
BCL2 in CRC patients (Fig.
3), indicating the regulatory function of LINC02418/miR-34b-5p/BCL2 axis in CRC.
BCL2 is believed to suppress apoptosis in a variety of tissues and cancers. BCL2 inhibits the release of cytochrome c and pro-apoptotic factors, so that the relevant factors are not able to initiate the downstream caspase pathway to activate Caspase 9 and Caspase 3 [
37]. The positive correlation between LINC02418 and BCL2 expression level suggested dysregulation of apoptosis might be associated with the contribution of LINC02418 in CRC progression. Western blot experiments showed in the presence of sh-LINC02418, protein level of cleaved-Caspase 9 and cleaved-Caspase 3 in CRC cells was significantly increased while BCL2 expression was inhibited, indicating silence of LINC02418 could improve cell apoptosis and reduce colon cancer cells growth (Fig.
5a). However, the protein level of BCL2 in cells with decreased LINC02418 was restored by miR-34b-5p inhibitor transfection. The CRC cells growth was also compensated either by down-regulation of mir-34b-5p or ectopic expression of BCL2 protein (Fig.
5b, c).
Combining all the evidence from the study, we speculated that in normal intestinal epithelial tissue, LINC02418 stays in a low level which leads to the expression of miR-34b-5p as well as low expression of BCL2. As a consequence, cell apoptosis is activated. However, in human CRC cells, LINC02418 expression is upregulated and the expression of miR-34b-5p and BCL2 are affected by increased level of LINC02418. Thus, cell apoptosis is inhibited, allowing cancer cells escaping from cell death and re-entering abnormal cell cycles.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.